Stericycle, Inc. (NASDAQ:SRCL) Shares Sold by Noesis Capital Mangement Corp

Noesis Capital Mangement Corp cut its holdings in Stericycle, Inc. (NASDAQ:SRCL) by 1.3% in the 4th quarter, HoldingsChannel reports. The fund owned 209,994 shares of the business services provider’s stock after selling 2,856 shares during the period. Stericycle makes up 2.5% of Noesis Capital Mangement Corp’s investment portfolio, making the stock its 17th largest position. Noesis Capital Mangement Corp’s holdings in Stericycle were worth $10,407,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Barclays PLC grew its position in Stericycle by 30.6% during the third quarter. Barclays PLC now owns 70,408 shares of the business services provider’s stock valued at $3,147,000 after acquiring an additional 16,505 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Stericycle by 17.3% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,078 shares of the business services provider’s stock worth $808,000 after purchasing an additional 2,671 shares in the last quarter. Earnest Partners LLC increased its position in Stericycle by 6.6% during the 3rd quarter. Earnest Partners LLC now owns 1,941,254 shares of the business services provider’s stock worth $86,793,000 after purchasing an additional 120,852 shares in the last quarter. Pathstone Family Office LLC purchased a new position in Stericycle in the third quarter valued at approximately $230,000. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its position in Stericycle by 25.7% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 67,860 shares of the business services provider’s stock valued at $3,034,000 after buying an additional 13,860 shares in the last quarter. 98.82% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

SRCL has been the topic of a number of research reports. Royal Bank of Canada reissued an “outperform” rating and issued a $69.00 target price on shares of Stericycle in a research note on Thursday, March 7th. Stifel Nicolaus boosted their price objective on Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a research note on Thursday, February 29th. Truist Financial lowered their target price on Stericycle from $57.00 to $50.00 and set a “hold” rating for the company in a research note on Monday, April 29th. Robert W. Baird reduced their price target on Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a research report on Friday, April 26th. Finally, Wells Fargo & Company increased their price objective on shares of Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research report on Friday, March 1st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Stericycle currently has a consensus rating of “Hold” and a consensus target price of $59.40.

Stericycle Stock Up 3.1 %

Shares of NASDAQ:SRCL traded up $1.38 during trading on Friday, hitting $46.18. The company’s stock had a trading volume of 423,599 shares, compared to its average volume of 506,754. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $57.06. The stock’s 50-day moving average price is $50.91 and its two-hundred day moving average price is $48.25. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11. The company has a market capitalization of $4.29 billion, a PE ratio of -209.91, a PEG ratio of 2.41 and a beta of 1.12.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.03. The firm had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The firm’s quarterly revenue was down 2.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.49 earnings per share. As a group, sell-side analysts expect that Stericycle, Inc. will post 2.32 EPS for the current year.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.